Constellation Pharmaceuticals
Clinical trials sponsored by Constellation Pharmaceuticals, explained in plain language.
-
New drug combo shows promise for rare blood cancers
Disease control CompletedThis study tested a new pill called pelabresib in people with certain blood cancers, including myelofibrosis and leukemia. The goal was to see if it could shrink enlarged spleens and reduce the need for blood transfusions. The drug was given alone or with another medicine (ruxoli…
Phase: PHASE1, PHASE2 • Sponsor: Constellation Pharmaceuticals • Aim: Disease control
Last updated May 08, 2026 12:01 UTC
-
New combo therapy shows promise for tough prostate cancer
Disease control CompletedThis study tested a new drug (CPI-1205) combined with standard hormone therapies (enzalutamide or abiraterone/prednisone) in 175 men with advanced prostate cancer that no longer responds to hormone therapy. The goal was to find the safest dose and see if the combination helps shr…
Phase: PHASE1, PHASE2 • Sponsor: Constellation Pharmaceuticals • Aim: Disease control
Last updated May 07, 2026 18:43 UTC